1999
DOI: 10.1016/s1056-8727(98)00020-8
|View full text |Cite
|
Sign up to set email alerts
|

The Relationship of Prorenin Values to Microvascular Complications in Patients with Insulin-Dependent Diabetes Mellitus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
8
0
1

Year Published

2001
2001
2021
2021

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 12 publications
(10 citation statements)
references
References 21 publications
1
8
0
1
Order By: Relevance
“…Progression of diabetes mellitus causes further accumulation of intracellular prorenin through inhibition of prorenin processing by transmural pressure, and the elevated intrarenal prorenin levels may lead to the increased plasma prorenin levels. These results could explain previous clinical reports demonstrating low renin and high prorenin levels in the blood of diabetics (1,(3)(4)(5)(6)(7).…”
Section: Discussionsupporting
confidence: 86%
“…Progression of diabetes mellitus causes further accumulation of intracellular prorenin through inhibition of prorenin processing by transmural pressure, and the elevated intrarenal prorenin levels may lead to the increased plasma prorenin levels. These results could explain previous clinical reports demonstrating low renin and high prorenin levels in the blood of diabetics (1,(3)(4)(5)(6)(7).…”
Section: Discussionsupporting
confidence: 86%
“…28 -30 This scenario would also account for the fact that prorenin predicts microvascular complications in patients with diabetes mellitus. [31][32][33] The recent identification of a binding site for renin and prorenin in human kidney mesangium and arteries has created a new interest in a role for prorenin in health and disease. 26 Until recently, prorenin, despite circulating at plasma concentrations 10-fold higher than those of renin, was thought to play a role in physiology only as a precursor to renin.…”
Section: ϫ2mentioning
confidence: 99%
“…in den Nieren, dem Herzen, den Augen, dem Gehirn und dem Fettgewebe vermittelt [6,9,15]. Man geht heute davon aus, dass die Aktivierung lokaler RAAS-Syste me in die Pathogenese von Erkrankungen wie Herzinsuffizienz, Diabetes mellitus, Retinopathie und Nephropathie involviert ist [7,10,11]. Die Effektivität einer therapeutischen RAAS-Blockade und die in der vorlie- [2].…”
Section: Diskussionunclassified